| Literature DB >> 32054075 |
Federico Armando1,2, Matteo Gambini1,3, Attilio Corradi2, Chiara Giudice3, Vanessa Maria Pfankuche1,4, Graham Brogden5, Friederike Attig1,4, Maren von Köckritz-Blickwede5,6, Wolfgang Baumgärtner1,4, Christina Puff1.
Abstract
Histiocytic sarcomas represent malignant tumors which require new treatment strategies. Canine distemper virus (CDV) is a promising candidate due to its oncolytic features reported in a canine histiocytic sarcoma cell line (DH82 cells). Interestingly, the underlying mechanism might include a dysregulation of angiogenesis. Based on these findings, the aim of the present study was to investigate the impact of a persistent CDV-infection on oxidative stress mediated changes in the expression of hypoxia-inducible factor (HIF)-1α and its angiogenic downstream pathway in DH82 cells in vitro. Microarray data analysis, immunofluorescence for 8-hydroxyguanosine, superoxide dismutase 2 and catalase, and flow cytometry for oxidative burst displayed an increased oxidative stress in persistently CDV-infected DH82 cells (DH82Ond pi) compared to controls. The HIF-1α expression in DH82Ond pi increased, as demonstrated by Western blot, and showed an unexpected, often sub-membranous distribution, as shown by immunofluorescence and immunoelectron microscopy. Furthermore, microarray data analysis and immunofluorescence confirmed a reduced expression of VEGF-B in DH82Ond pi compared to controls. In summary, these results suggest a reduced activation of the HIF-1α angiogenic downstream pathway in DH82Ond pi cells in vitro, most likely due to an excessive, unusually localized, and non-functional expression of HIF-1α triggered by a CDV-induced increased oxidative stress.Entities:
Keywords: DH82; HIF-1α; VEGF-B; angiogenesis; canine distemper virus; canine histiocytic sarcoma; oxidative stress; viral oncolysis
Mesh:
Substances:
Year: 2020 PMID: 32054075 PMCID: PMC7077254 DOI: 10.3390/v12020200
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Details of the antibodies used for the immunostaining performed, including primary antibody, host species, clonality, epitope retrieval method, blocking serum, dilution of primary antibody, secondary antibody and positive control.
| Primary Antibody | Host Species, Clonality | Epitope Retrieval | Serum Blocking | Dilution | Secondary Antibody (1:200) | Positive Control |
|---|---|---|---|---|---|---|
| CDV-NP (University of Bern) | Mouse, monoclonal, clone D110 | Citrate buffer, microwave | PBST + 3% BSA + 5% goat serum | 1:100 | GaM-Cy3 or GaM-Cy2 | n/a |
| 8OHdG (Abcam, Cambridge, USA) | Goat, polyclonal | Proteinase K | PBST + 3% BSA + 5% horse serum | 1:200 | DaG-Cy3 | Canine pyo-granu-lomatous endo- metritis |
| SOD2 (Abcam, Cambridge, USA) | Rabbit, polyclonal | Citrate buffer, microwave | PBST + 3% BSA + 5% goat serum | 1:200 | GaR-Cy2 | Canine brain and spinal cord |
| CAT (Abcam, Cambridge, USA) | Goat, polyclonal | Citrate buffer, microwave | PBST + 3% BSA + 5% horse serum | 1:50 | DaG-Cy3 | Canine spinal cord with fibro-carti- lagineous embolus |
| HIF-1α (Novus Biologicals, Colorado, USA) | Rabbit, polyclonal | Citrate buffer, microwave | PBST + 3% BSA + 5% goat serum | 1:500 | GaR-Cy3 or DaR-Cy2 | Canine mammary adeno- carcinoma with central necrosis |
| Wheat germ agglutinin (WGA) AF633 conjugated (Invitrogen, California, USA) | none | Citrate buffer, microwave | n/a | 1:20 | n/a | n/a |
| CD63 (Sicgen, Coimbra, Portugal) | Goat, polyclonal | Citrate buffer, microwave | PBST + 3% BSA + 5% horse serum | 1:200 | DaG-Cy3 | MDCK cell pellet |
| GM-130 (BD Transduction Laboratories, North Carolina, USA) | Mouse, monoclonal, clone 35/GM130 (RUO) | Citrate buffer, microwave | PBST + 3% BSA + 5% goat serum | 1:200 | GaM-Cy2 | n/a |
| VEGF-B (My Biosource, California, USA) | Rabbit, polyclonal | Citrate buffer, microwave | PBST + 3% BSA + 5% goat serum | 1:40 | GaR-Cy3 | Canine fetal brain, liver and kidney |
BSA, bovine serum albumin; CDV-NP, canine distemper virus nucleoprotein; DaG-Cy3, donkey anti goat cyanine 3-conjugated; DaR-Cy2, donkey anti rabbit cyanine 2-conjugated; GaM-Cy2, goat anti mouse cyanine 2-conjugated; GaM-Cy3, goat anti mouse cyanine 3-conjugated; GaR-Cy2, goat anti rabbit cyanine 2-conjugated; GaR-Cy3, goat anti rabbit cyanine 3-conjugated; GM130, Golgi membrane protein of 130 kDa; HIF-1α, hypoxia-inducible factor 1 α; MDCK, Madin-Darby canine kidney cells; n/a, non applied or non applicable; PBST, phosphate buffered saline Tween-20; SOD2, superoxide dismutase 2; VEGF-B, vascular endothelial growth factor-B; WGA, wheat germ agglutinin; 8OHdG, 8-hydroxyguanosine/8-hydroxydeoxyguanosine.
Summary of canine gene symbols related to ROS production and scavenging, ER-stress and HIF-1α pathway, differentially expressed between non-infected and persistently canine distemper virus infected DH82 cells, according to the combination of a fold change (FC) filter (FC ≥ 1.5 or ≤ −1.5) and of a statistical significances filter (p ≤ 0.05).
| Canine Gene Symbol | Gene Name | Functional Group | Fold Change | References | |
|---|---|---|---|---|---|
| vascular endothelial growth factor B | HIF-1a downstream | −593.197 | <0.001 | [ | |
| thrombospondin 2 | HIF-1a downstream | −451.295 | <0.001 | [ | |
| endothelin 1 | HIF-1a downstream | −47.795 | <0.001 | [ | |
| chemokine (C-X-C motif) receptor 4 | HIF-1a downstream | −13.485 | <0.001 | [ | |
| serine (or cysteine) peptidase inhibitor, clade E, member 1 | HIF-1a downstream | −13.116 | <0.001 | [ | |
| cytochrome c oxidase subunit VIIb2 | ROS production; ER stress | −6.015 | <0.001 | [ | |
| inositol 1,4,5-triphosphate receptor, type 3 | ER stress | −4.646 | <0.001 | [ | |
| thrombospondin 1 | HIF-1a downstream | −4.461 | <0.001 | [ | |
| ERO1-like ( | ROS production; ER stress | −3.995 | <0.001 | [ | |
| chemokine (C-X-C motif) ligand 12 | HIF-1a downstream | −3.683 | <0.001 | [ | |
| 5’-nucleotidase, ecto (CD73) | HIF-1a downstream | −3.041 | <0.001 | [ | |
| calnexin | ER stress | −2.780 | <0.001 | [ | |
| thioredoxin reductase 3 | ROS scavenging | −2.464 | <0.001 | [ | |
| NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2 | ROS production; ER stress | −2.292 | <0.001 | [ | |
| NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa | ROS production; ER stress | −2.261 | <0.001 | [ | |
| DNA-damage-inducible transcript 3 | ER stress | −2.087 | <0.001 | [ | |
| Egl nine homolog 1 ( | HIF-1a transcription & regulation | −1.976 | 0.001 | [ | |
| peroxiredoxin 6 | ROS scavenging | −1.895 | <0.001 | [ | |
| egl nine homolog 3 ( | HIF-1a transcription & regulation | −1.875 | 0.004 | [ | |
| succinate dehydrogenase complex, subunit D, integral membrane protein | ROS production; ER stress | −1.857 | <0.001 | [ | |
| fibroblast growth factor 2 (basic) | HIF-1a downstream | −1.842 | 0.003 | [ | |
| protein disulfide isomerase family A, member 6 | ROS production; ER stress | −1.801 | <0.001 | [ | |
| von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase | HIF-1a transcription & regulation | −1.771 | 0.005 | [ | |
| superoxide dismutase 1, soluble | ROS scavenging | −1.712 | <0.001 | [ | |
| protein disulfide isomerase family A, member 4 | ROS production; ER stress | −1.678 | 0.010 | [ | |
| adrenomedullin | HIF-1a downstream | −1.665 | <0.001 | [ | |
| glutathione synthetase | ROS scavenging; ER stress | −1.648 | 0.001 | [ | |
| NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa | ROS production; ER stress | −1.630 | 0.001 | [ | |
| glutamate-cysteine ligase, modifier subunit | ROS scavenging; ER stress | −1.565 | <0.001 | [ | |
| protein disulfide isomerase family A, member 3 | ROS production; ER stress | −1.533 | 0.001 | [ | |
| CD274 molecule | HIF-1a downstream | −1.515 | 0.025 | [ | |
| platelet-derived growth factor receptor-like | HIF-1a downstream | 1.554 | 0.004 | [ | |
| ubiquinol-cytochrome c reductase (6.4kD) subunit | ROS production; ER stress | 1.563 | 0.002 | [ | |
| ubiquinol cytochrome c reductase core protein 2 | ROS production; ER stress | 1.590 | 0.021 | [ | |
| NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) | ROS production; ER stress | 1.622 | <0.001 | [ | |
| neutrophil cytosolic factor 2 | ROS production | 1.639 | 0.004 | [ | |
| ubiquinol-cytochrome c reductase core protein 1 | ROS production; ER stress | 1.678 | <0.001 | [ | |
| inositol 1,4,5-triphosphate receptor, type 1 | ER stress | 1.844 | 0.001 | [ | |
| NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) | ROS production; ER stress | 1.846 | <0.001 | [ | |
| lon peptidase 1, mitochondrial | ER stress | 1.850 | 0.001 | [ | |
| chemokine (C-C motif) ligand 2 | HIF-1a downstream | 1.866 | <0.001 | [ | |
| heme oxygenase (decycling) 1 | ROS scavenging | 1.940 | <0.001 | [ | |
| NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa | ROS production; ER stress | 2.009 | <0.001 | [ | |
| platelet-derived growth factor alpha polypeptide | HIF-1a downstream | 2.089 | <0.001 | [ | |
| peptidylprolyl isomerase D (cyclophilin D) | ER stress | 2.286 | <0.001 | [ | |
| NADH dehydrogenase (ubiquinone) flavoprotein 3 | ROS production; ER stress | 2.362 | <0.001 | [ | |
| arachidonate 5-lipoxygenase-activating protein | ROS production | 2.509 | <0.001 | [ | |
| COX17 homolog, cytochrome c oxidase assembly protein | ROS production; ER stress | 2.557 | 0.001 | [ | |
| Catalase | ROS scavenging | 3.584 | <0.001 | [ | |
| NAD(P)H dehydrogenase, quinone 1 | ROS scavenging | 3.868 | <0.001 | [ | |
| xanthine dehydrogenase | ROS production; ER stress | 3.913 | 0.002 | [ | |
| KIT ligand | HIF-1a downstream | 4.174 | <0.001 | [ | |
| peroxiredoxin-2-like | ROS scavenging | 5.351 | <0.001 | [ | |
| endothelial-specific receptor tyrosine kinase | HIF-1a downstream | 5.639 | <0.001 | [ | |
| platelet derived growth factor C | HIF-1a downstream | 6.578 | <0.001 | [ | |
| thioredoxin interacting protein | ROS scavenging | 11.227 | 0.001 | [ | |
| neutrophil cytosolic factor 4, 40kDa | ROS production | 67.304 | <0.001 | [ |
Green labeling refers to down-regulated genes; red refers to up-regulated genes. ER, endoplasmic reticulum; HIF-1α, hypoxia-inducible factor 1α; ROS, reactive oxygen species. “HIF-1α transcription & regulation” is the abbreviation for “HIF-1α activation, transcriptional activity and regulation” functional group; “HIF-1α downstream” is the abbreviation for “HIF-1α angiogenic downstream pathway” functional group.
Figure 1Immunofluorescence analysis revealed a lower expression of markers associated with oxidative stress in non-infected (A,D,G) compared to persistently canine distemper virus (CDV) infected (B,E,H) DH82 cells. Staining for 8OHdG (Cy3, red) and bisbenzimide (nuclei, blue) revealed a similar expression in non-infected (A) and persistently CDV-infected (B) DH82 cells as graphically shown in (C). Staining for superoxide dismutase (Cy2, green) and bisbenzimide (nuclei, blue) showed a significantly lower expression in non-infected (D) compared to persistently CDV-infected DH82 (E) cells as graphically depicted in (F). Staining for catalase (Cy3, red) and bisbenzimide (nuclei, blue) demonstrated a significantly lower expression in non-infected (G) compared to persistently CDV-infected (H) DH82 cells as graphically shown in (I). Bar = 20µm. (C), (F) and (I) display box and whisker plots with median values, quartiles and maximum and minimum values. Significant differences (p ≤ 0.05, Mann–Whitney U-test) are labeled by asterisks (** p ≤ 0.01).
Figure 2Determination of oxidative burst by fluorescence activated cells sorting (FACS) in non-infected (A) and persistently canine distemper virus (CDV) infected (B) DH82 cells. The percentage of cells positive for ROS-formation was measured by flow cytometry (BL-1) using a DCF fluorescence probe. (C) BL-1 positive cells revealed a significantly increased ROS production among persistently CDV-infected DH82 cells compared to non-infected controls. All data are shown as dot plots with means ± standard error of mean. Significant differences (p ≤ 0.05, unpaired t-test) are labeled by asterisks (** p ≤ 0.01).
Figure 3Immunofluorescence analysis for HIF-1α expression (Cy3, red; bisbenzimide, blue, nuclei) reveals a lower membranous expression in non-infected (A) compared to persistently canine distemper virus (CDV) infected (B) DH82 cells. Non-infected DH82 cells frequently displayed a nuclear immunolabeling (A) whereas a frequent membrane-associated staining was observed in persistently CDV-infected DH82 cells (B). Bar = 20µm. HIF-1α shows a significantly increased percentage of positive cells in persistently CDV-infected DH82 cells compared to non-infected controls (C). (D) Within non-infected DH82 cells, HIF-1α was present within nucleus and cytoplasm without significant differences between the localizations. In contrast, persistently CDV-infected DH82 cells displayed a significantly higher membranous HIF-1α expression compared to nuclear (p = 0.0486) but not to cytoplasmic (p = 0.0710) localizations. Additionally, the membranous immunopositivity for HIF-1α in persistently CDV-Ond infected DH82 cells was significantly higher compared to the corresponding localization in non-infected controls. Box and whisker plots display median and quartiles with maximum and minimum values. Significant differences (p ≤ 0.05, Mann–Whitney U-test (C,D) and Kruskall-Wallis test with post-hoc Dunn’s test (D)) are labeled by asterisks (* p ≤ 0.05 and ** p ≤ 0.01).
Figure 4Immunoblotting with anti-HIF-1α and anti-β-actin antibodies revealed a single band of approximately 130 kDa and 43 kDa, respectively, when compared to the corresponding marker lengths of 130 kDa and 35 kDa (arrows, A). (B) Band intensities and sizes of both HIF-1α and beta-actin were quantified and their ratio determined, revealing a significant increase of HIF-1α in persistently canine distemper virus (CDV)-infected DH82 cells compared to non-infected controls. Dot plots display means and standard deviation. Significant differences (p ≤ 0.05, unpaired t-test.) are labeled by asterisks (** p ≤ 0.01).
Figure 5Demonstration of the intracellular HIF-1α localization in persistently canine distemper virus infected DH82 cells as determined by immunoelectron microscopy. (A) HIF-1α was found within variably sized, round, moderately to highly electrondense vesicles (insert) and in large moderately electrondense vacuoles (*). Additionally, HIF-1α was detected often in the sub-membranous area of the cytoplasm (insert; B). Magnification 9000×.
Figure 6(A) The intracellular HIF-1α localization was analyzed by double immunofluorescence with HIF-1α (Cy2, green) and CD63 (Cy3, red) in persistently canine distemper virus (CDV)-infected DH82 cells. Both proteins were localized within cell membranes and cytoplasm. Interestingly, an occasional co-expression (yellow) was noted (arrows; insert) using scanning confocal laser microscopy. (B) A double labeling directed against HIF-1α (Cy3, red) and the CDV nucleoprotein (CDV-NP; Cy2, green) revealed a frequent co-localization (yellow) beneath the cell membrane and within the perinuclear area (insert) of persistently CDV-infected DH82 cells. Nuclei were stained with bisbenzimide (blue). Bar = 20 µm.
Figure 7Immunofluorescence analysis for vascular endothelial growth factor B (VEGF-B, Cy3, red) revealed a high expression of this marker in non-infected DH82 cells (A), whereas a low expression was present in persistently canine distemper virus (CDV)-infected DH82 cells (B); Bar = 20 µm. This statistically significant difference is graphically shown in (C). Box and whisker plots display median and quartiles with maximum and minimum values. Significant differences (p ≤ 0.05, Mann–Whitney U-test) are labeled by asterisks (** p ≤ 0.01).